IP Library Granted Patent US 10,179,235
Granted Patent B2
US 10,179,235 · App. 15/729,326 · Granted Jan 15, 2019

Methods and apparatus for bilateral renal neuromodulation

Inventors: Denise Zarins (Saratoga, CA); Hanson Gifford, III (Woodside, CA); Mark Deem (Mountain View, CA); Douglas Sutton (Pacifica, CA); Howard R. Levin (Teaneck, NJ); Mark Gelfand (New York, NY)
Assignee: Medtronic Ardian Luxembourg S.a.r.l.
A61N1/0551A61B18/12A61B18/14A61B18/1492A61M5/1408A61M5/14276A61N1/0412A61N1/05A61N1/327A61N1/36007A61N1/36017A61B2018/00267A61B2018/00351A61B2018/00404A61B2018/00434A61B2018/00511A61B2018/00577A61B2018/00613A61M2210/1082A61N7/00
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,179,235
App. No.
15/729,326
Granted
Jan 15, 2019
Kind
B2
Abstract

Methods and apparatus are provided for bilateral renal neuromodulation, e.g., via a pulsed electric field, via a stimulation electric field, via localized drug delivery, via high frequency ultrasound, via thermal techniques, etc. Such neuromodulation may effectuate irreversible electroporation or electrofusion, necrosis and/or inducement of apoptosis, alteration of gene expression, action potential attenuation or blockade, changes in cytokine up-regulation and other conditions in target neural fibers. In some embodiments, neuromodulation is applied to neural fibers that contribute to renal function. In some embodiments, such neuromodulation is performed in a bilateral fashion. Bilateral renal neuromodulation may provide enhanced therapeutic effect in some patients as compared to renal neuromodulation performed unilaterally, i.e., as compared to renal neuromodulation performed on neural tissue innervating a single kidney.

Claims (33)

1. A method for treatment of a hypertensive human patient, the method comprising:

intravascularly positioning a catheter within a first renal artery associated with a first kidney of the patient;

ablating renal nerves along the first renal artery via first ultrasound energy from the catheter;

intravascularly positioning the catheter within a second renal artery associated with a second kidney of the patient; and

ablating renal nerves along the second renal artery via second ultrasound energy from the catheter,

wherein ablating renal nerves along the first renal artery and ablating renal nerves along the second renal artery results in a therapeutically beneficial reduction in blood pressure of the hypertensive patient.

2. The method of claim 1 , further comprising removing the catheter from the patient after delivering the first and second ultrasound energy to conclude the procedure.

3. The method of claim 1 wherein the first ultrasound energy is the same as the second ultrasound energy.

4. The method of claim 1 wherein the first ultrasound energy and the second ultrasound energy are both high frequency ultrasound energy.

5. The method of claim 1 wherein ablating renal nerves along the first renal artery and ablating renal nerves along the second renal artery further results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

6. A method for treating a hypertensive human patient, the method comprising:

intravascularly positioning a first catheter within a first renal blood vessel of the patient and adjacent to renal nerves innervating a first kidney of the patient;

delivering, via the first catheter, first ultrasound energy to the renal nerves disposed adjacent to the first renal blood vessel, wherein the first ultrasound energy attenuates neural traffic along the renal nerves innervating the first kidney;

intravascularly positioning a second catheter within a second renal blood vessel of the patient and adjacent to renal nerves innervating a second kidney of the patient;

delivering, via the second catheter, second ultrasound energy to the renal nerves disposed adjacent to the second renal blood vessel, wherein the second ultrasound energy attenuates neural traffic along the renal nerves innervating the second kidney, wherein attenuating neural traffic along the renal nerves innervating the first kidney and renal nerves innervating the second kidney results in a therapeutically beneficial improvement in one or more physiological conditions associated with hypertension of the patient.

7. The method of claim 6 wherein intravascularly positioning the first catheter within the first renal blood vessel of the patient and intravascularly positioning the second catheter within the second renal blood vessel of the patient occur simultaneously.

8. The method of claim 6 wherein:

intravascularly positioning a first catheter within a first renal blood vessel of the patient comprises intravascularly delivering the first catheter to the first renal blood vessel over a first guidewire; and

intravascularly positioning a second catheter within a second renal blood vessel of the patient comprises intravascularly delivering the second catheter to the second renal blood vessel over a second guidewire.

9. The method of claim 6 , further comprising removing the first catheter from the first renal blood vessel of the patient before positioning the second catheter within the second renal blood vessel of the patient.

10. The method of claim 6 wherein:

attenuating neural traffic along the renal nerves innervating the first kidney comprises ablating the renal nerves innervating the first kidney; and

attenuating neural traffic along the renal nerves innervating the second kidney comprises ablating the renal nerves innervating the second kidney.

11. The method of claim 6 wherein:

attenuating neural traffic along the renal nerves innervating the first kidney comprises partially ablating the renal nerves innervating the first kidney; and

attenuating neural traffic along the renal nerves innervating the second kidney comprises partially ablating the renal nerves innervating the second kidney.

12. The method of claim 6 wherein:

attenuating neural traffic along the renal nerves innervating the first kidney comprises reducing renal sympathetic nerve activity of the first kidney; and

attenuating neural traffic along the renal nerves innervating the second kidney comprises reducing renal sympathetic nerve activity of the second kidney.

13. The method of claim 6 wherein attenuating neural traffic along the renal nerves innervating the first kidney and the renal nerves innervating the second kidney results in a therapeutically beneficial reduction in central sympathetic overactivity of the patient.

14. The method of claim 6 wherein the first ultrasound energy is the same as the second ultrasound energy.

15. The method of claim 6 wherein the first ultrasound energy is high frequency ultrasound energy.

16. The method of claim 6 wherein intravascularly positioning the first catheter within the first renal blood vessel of the patient and intravascularly positioning the second catheter within the second renal blood vessel of the patient occur sequentially.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: DEMARAIS, DENISE; GIFFORD, HANSON, III; DEEM, MARK; SUTTON, DOUGLAS; LEVIN, HOWARD R.; GELFAND, MARK
To: ARDIAN, INC.
Reel/Frame 047565/0956 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 21, 2018
From: MEDTRONIC ARDIAN LLC
To: MEDTRONIC ARDIAN LUXEMBOURG S.A.R.L.
Reel/Frame 047566/0134 →
CHANGE OF NAME Recorded Nov 21, 2018
From: ARDIAN, INC.
To: MEDTRONIC ARDIAN LLC
Reel/Frame 047618/0598 →
Continuity (24)
Continuation 15269010 · Sep 19, 2016
Continuation 14816115 · Aug 3, 2015
Continuation 14260060 · Apr 23, 2014
Continuation 14034434 · Sep 23, 2013
Continuation 13361685 · Jan 30, 2012
Division 11368836 · Mar 6, 2006
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11133925 · May 20, 2005
Continuation 10900199 · Jul 28, 2004
Continuation In Part 10408665 · Apr 8, 2003
Continuation In Part 11129765 · May 13, 2005
Continuation In Part 11363867 · Feb 27, 2006
Continuation In Part 11266993 · Nov 4, 2005
Continuation In Part 11189563 · Jul 25, 2005
Continuation In Part 11129765 · May 13, 2005
Provisional Application 60813589 · Dec 29, 2005
Provisional Application 60624793 · Nov 2, 2004
Provisional Application 60616254 · Oct 5, 2004
Provisional Application 60442970 · Jan 29, 2003
Provisional Application 60415575 · Oct 3, 2002
Provisional Application 60370190 · Apr 8, 2002
Related Publication 20180078758A1 · Mar 22, 2018